3 Penny Stocks For Your September Watchlist
Making a penny stocks watchlist for September? Well, there are a few things you should keep in mind. First and foremost is the trajectory of the pandemic. With Covid cases rising in most of the world and the U.S. particularly, many investors are showing uncertainty about the near future.
And the result of this is rather volatile trading patterns with both penny stocks and blue chips. However, in the past week or so, we have seen more bullish sentiment than usual, indicating that we could be nearing a turnaround point. This ebb and flow is natural, and something that investors witness on a daily basis.
However, with Covid, things change extremely quickly from day to day. And, with a new month on the horizon, many investors are hopeful about the future. While a new month is not a complete paradigm shift for the stock market, it does present a clean slate. And for that reason, here are three penny stocks to keep an eye on in September 2021.
3 Penny Stocks to Watch in September 2021
- Advaxis Inc. (NASDAQ: ADXS)
- Kaixin Auto Holdings (NASDAQ: KXIN)
- Senseonics Holdings Inc. (NYSE: SENS)
Advaxis Inc. (NASDAQ: ADXS)
Advaxis Inc. is a penny stock that is up by over 14% in the past month, indicating sizable bullish sentiment. This company discovers, develops, and commercializes a broad range of medical technologies. Its main development is Listeria monoxytogens tech antigen delivery products. Within this, it is in a Phase 2 trial for its ADXS-PSA for treating metastatic prostate cancer. The company is also developing a variety of other compounds for the treatment of cancer.
In July, the company announced the initiation of a Phase 1 clinical trial for ADXS-504. This clinical trial was made for the treatment of early prostate cancer. This is the first-ever clinical evaluation of ADXS-504, which is Advaxis’ off-the-shelf neoantigen immunotherapy drug candidate.
“This Phase 1 study will evaluate the safety, tolerability, immunogenicity and clinical activity of ADXS-504 in men who have undergone radical prostatectomy or radiotherapy and whose prostate-specific antigen (PSA) levels in the blood are rising, which we believe are ideal patients to evaluate with this approach.”Chief Medical Officer of Advaxis, Dr. Andres Gutierrez
Since this update was released, ADXS stock has gone up in price including a 7% gain on August 26th. With this in mind, will ADXS stock be on your penny stocks watchlist in 2021?
Kaixin Auto Holdings (NASDAQ: KXIN)
Kaixin Auto Holdings is a penny stock we have mentioned numerous times in the past few months due to its frequent market momentum. For those unfamiliar, Kaixin operates 14 used car dealerships across China. It also provides financing channels to its customers through its partnerships with various financial institutions. It additionally provides insurance, extended warranties, and after-sales services.
A few weeks ago, Kaixin announced that it has plans to create smaller size electric vehicles. This is a large growing market in China at the moment. Now on August 26th, the company has announced a binding term sheet to acquire 100% of Henen Yujie Times Automobile Co. Ltd. through new share issuance.
Yujie is one of the leading Chinese EV manufacturers at the moment so this is a huge deal for Kaixin. While it doesn’t make KXIN a pure-play EV penny stock, it does show that Kaixin is working hard to stay as prominent as possible. And, if we consider the massive growth of the EV market, we see just why this could be big news for KXIN investors.
This announcement is Kaixin’s official entrance to the China small size EV market. Yujie believes that this market will reach 10 million vehicles in the next 5 years. Currently, Yujie’s factory has an annual production capacity of 150,000 vehicles. Kaixin will now negotiate further details of acquisition with Yujie consistent with the term sheet. Keeping all of this in mind, will KXIN stock be on your list of penny stocks to watch next month?
Senseonics Holdings Inc. (NYSE: SENS)
Senseonics Holdings Inc. is a biotech company that creates a wide range of medical tech products aimed at monitoring and treating diabetes. The company both develops and commercializes continuous glucose monitoring systems for people with diabetes. Its products include Eversense and Eversense XL, which are both implantable CGM systems to measure glucose levels in people with diabetes.
On August 9th, Senseonics reported its second-quarter financial results for 2021. The company generated revenue of $3.3 million during the quarter. Senseonics also raised $50 million in gross proceeds through the completion of an at-the-market equity offering program.
Senseonics is working hard to grow, and that involves getting its Eversense systems into as many hands as it can. With millions suffering from diabetes around the world, Senseonics has a large market opportunity to take advantage of. And, the current methods of glucose monitoring are out of date and unnecessarily invasive.
“In the second quarter we made progress driving increased patient and provider awareness of Eversense through a targeted direct-to-consumer digital advertising campaign and presentations of the PROMISE Study, an evaluation of our 180-day sensor, at the ADA and ATTD conferences.”Tim Goodnow, the President and CEO of Senseonics
When these results were released, SENS stock was at $3.26 per share on average. Now on August 26th, SENS stock has reached $3.80 per share on average. With this in mind, will you add SENS to your list of penny stocks to watch?
Are Penny Stocks Worth it or Not?
Finding the best penny stocks to buy right now can be difficult with so much going on in the world. And when we look at the specific factors impacting the stock market such as Covid and inflation in the U.S., we see that it may be difficult to predict the future.
However, if investors pay close attention to what’s going on, it can be much easier to make a game plan for the future. And with a proper strategy, making money with penny stocks can be easy. With all of this in mind, are penny stocks worth it or not?